Olaparib for DNA repair-deficient prostate cancer — one for all, or all for one?

Emmanuel S. Antonarakis

School of Medicine

Research output: Contribution to journal › Article

Original language	English (US)
Pages (from-to)	455-456
Number of pages	2
Journal	Nature Reviews Clinical Oncology
Volume	17
Issue number	8
DOIs	https://doi.org/10.1038/s41571-020-0395-x
State	Published - Aug 1 2020

ASJC Scopus subject areas

Oncology

Access to Document

10.1038/s41571-020-0395-x

Cite this

Antonarakis, E. S. (2020). Olaparib for DNA repair-deficient prostate cancer — one for all, or all for one? Nature Reviews Clinical Oncology, 17(8), 455-456. https://doi.org/10.1038/s41571-020-0395-x

@article{17a581374bb84fd59973358ec89e1aa7,

title = "Olaparib for DNA repair-deficient prostate cancer — one for all, or all for one?",

author = "Antonarakis, {Emmanuel S.}",

year = "2020",

month = aug,

day = "1",

doi = "10.1038/s41571-020-0395-x",

language = "English (US)",

volume = "17",

pages = "455--456",

journal = "Nature Reviews Clinical Oncology",

issn = "1759-4774",

number = "8",

}

TY - JOUR

T1 - Olaparib for DNA repair-deficient prostate cancer — one for all, or all for one?

AU - Antonarakis, Emmanuel S.

PY - 2020/8/1

Y1 - 2020/8/1

UR - http://www.scopus.com/inward/record.url?scp=85084984208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85084984208&partnerID=8YFLogxK

U2 - 10.1038/s41571-020-0395-x

DO - 10.1038/s41571-020-0395-x

M3 - Article

C2 - 32447344

AN - SCOPUS:85084984208

VL - 17

SP - 455

EP - 456

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

SN - 1759-4774

IS - 8

ER -